Bard-Chapeau et al. demonstrated that mice with hepatocyte-specific deletion of SHP2 are more sensitive to diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC), and STAT3 is required for the promotion of HCC development induced by SHP2 deletion11. Here, PTPN11 is linked to hepatocellular carcinoma.